Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

ProFunds Biotechnology UltraSector ProFund

+ Add to Watchlist

BIPIX:US

66.01 USD 2.32 3.40%

As of 09:29:30 ET on 01/28/2015.

Snapshot for ProFunds Biotechnology UltraSector ProFund (BIPIX)

Year To Date: +4.45% 3-Month: +2.83% 3-Year: +65.89% 52-Week Range: 38.34 - 69.68
1-Month: +2.48% 1-Year: +43.33% 5-Year: +42.97% Beta vs DJUSBT: 1.34

Mutual Fund Chart for BIPIX

No chart data available.
  • BIPIX:US 66.01
  • 1M
  • 1Y
Interactive BIPIX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BIPIX

ProFunds Biotechnology UltraSector ProFund is an open-end fund incorporated in the USA. The Fund's objective is daily investment results, before fees and expenses, that correspond to one and one-half times (150%) of the performance of the Dow Jones U.S. Biotechnology Index. The Fund invests in biotechnology companies or in instruments that provide exposure to these companies.

Inception Date: 06-19-2000 Telephone: 1-240-497-6400
Managers: TODD BRUCE JOHNSON / HOWARD S RUBIN
Web Site: www.profunds.com

Fundamentals for BIPIX

NAV (on 2015-01-28) 66.01
Assets (M) (on 2014-12-31) 715.53
Fund Leveraged Y
Fund Leverage Percent Y
Minimum Investment 5,000.00
Minimum Subsequent Investment 0.00

Dividends for BIPIX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2014-12-15) 6.58
Dividend Yield (ttm) 10.02

Fees & Expenses for BIPIX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.75
Redemption Fee 0.00
12b1 Fee 0.00
Expense Ratio 1.57

Top Fund Holdings for BIPIX

Filing Date: 10/31/2014
Name Position Value % of Total
Gilead Sciences Inc 878,350 98,375,200 13.974%
Amgen Inc 440,772 71,484,403 10.154%
AbbVie Inc 924,663 58,679,114 8.335%
Celgene Corp 464,727 49,767,614 7.069%
Biogen Idec Inc 137,342 44,097,769 6.264%
Alexion Pharmaceuticals Inc 114,984 22,003,338 3.125%
Regeneron Pharmaceuticals Inc 43,119 16,976,813 2.411%
Illumina Inc 81,447 15,685,063 2.228%
Vertex Pharmaceuticals Inc 138,939 15,650,089 2.223%
BioMarin Pharmaceutical Inc 84,641 6,982,883 0.992%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil